|
Recent Newsletters
Left bundle branch block after TAVR | FDA approves tirzepatide, Eli Lilly’s new type 2 diabetes drug |
Key updates from SCAI 2022 | How cardiologists can make an impact in the face of anti-abortion laws |
Week in Review: New bleeding stroke guidelines | The ongoing contrast shortage & cath labs | TAVR vs. surgery |
Heart Failure: An update on the pig heart transplant patient | 4 promising therapies to keep an eye on |
What the contrast shortage means for interventional cath labs | IVL tied to superior long-term PAD, PCI outcomes |
Vascular & Endovascular: New bleeding stroke guidelines | Shielding during EVAR | Carotid endarterectomy & dementia |
TAVR vs. surgery: A new look at 1-year outcomes | DOJ says cardiologist created & sold ransomware tools |